BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23417988)

  • 1. Regulation of matrixmetalloproteinase-3 and matrixmetalloproteinase-13 by SUMO-2/3 through the transcription factor NF-κB.
    Frank S; Peters MA; Wehmeyer C; Strietholt S; Koers-Wunrau C; Bertrand J; Heitzmann M; Hillmann A; Sherwood J; Seyfert C; Gay S; Pap T
    Ann Rheum Dis; 2013 Nov; 72(11):1874-81. PubMed ID: 23417988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
    Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
    Lauder SN; Carty SM; Carpenter CE; Hill RJ; Talamas F; Bondeson J; Brennan P; Williams AS
    Rheumatology (Oxford); 2007 May; 46(5):752-8. PubMed ID: 17218328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts.
    Chi PL; Luo SF; Hsieh HL; Lee IT; Hsiao LD; Chen YL; Yang CM
    Arthritis Rheum; 2011 Oct; 63(10):2905-17. PubMed ID: 21702012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
    Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
    J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis.
    Wang L; Song G; Zheng Y; Tan W; Pan J; Zhao Y; Chang X
    Arthritis Res Ther; 2015 Aug; 17(1):227. PubMed ID: 26303122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
    Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
    Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs.
    Yoon HY; Lee EG; Lee H; Cho IJ; Choi YJ; Sung MS; Yoo HG; Yoo WH
    Int J Mol Med; 2013 Oct; 32(4):971-7. PubMed ID: 23934131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
    Kim KS; Oh DH; Choi HM; Bang JS; Ryu CJ; Kim JH; Yoo MC; Yang HI
    Eur J Pharmacol; 2009 Jun; 613(1-3):167-75. PubMed ID: 19379726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
    Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
    Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
    Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
    Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Kubota A; Hasegawa K; Suguro T; Koshihara Y
    J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-endorphin ameliorates synovial cell hyperfunction in the collagen-induced arthritis rat model by specific downregulation of NF-kappa B activity.
    Yin H; Zhang F; Yu M; Cheng H; Lin J; Gao Y; Han B; Zhu L
    Neuroendocrinology; 2005; 81(1):10-8. PubMed ID: 15802927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
    Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.
    Luo SF; Fang RY; Hsieh HL; Chi PL; Lin CC; Hsiao LD; Wu CC; Wang JS; Yang CM
    Arthritis Rheum; 2010 Jan; 62(1):105-16. PubMed ID: 20039412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.